Timeline

Nadira Frescaline
Post-doc
02 Oct 2024
publication
Infected wound repair correlates with collagen I induction and NOX2 activation by cold atmospheric plasma.
Read more22 Feb 2023
publication
Complete Genome Sequences of Bioluminescent Staphylococcus aureus Strains Xen31 and Xen36, Derived from Two Clinical Isolates.
Read more09 Sep 2022
project
NOVOPLASM – Novel perspective for cold plasma application in the treatment of severe and infected burn wounds
Read more01 Jan 2022
publication
Danger signals in traumatic hemorrhagic shock and new lines for clinical applications.
Read more16 Jun 2021
publication
Cold Atmospheric Plasma Promotes Killing of Staphylococcus aureus by Macrophages.
Read more01 Dec 2020
publication
Physical plasma therapy accelerates wound re-epithelialisation and enhances extracellular matrix formation in cutaneous skin grafts.
Read more28 Aug 2020
08 Aug 2020
01 Nov 2019
publication
Cold atmospheric plasma modulates endothelial nitric oxide synthase signalling and enhances burn wound neovascularisation.
Read more01 Jan 2018
publication
Mesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and Challenges.
Read more01 Dec 2016
publication
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis.
Read more01 Dec 2016
publication
Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis.
Read more05 Jul 2016
21 Mar 2015
publication
Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis.
Read more01 Jan 2015
publication
Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis.
Read more01 Nov 2014
publication
The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Read more01 Feb 2014
publication
Attenuation of flightless I improves wound healing and enhances angiogenesis in a murine model of type 1 diabetes.
Read more01 Oct 2013
publication
Venous ulceration contaminated by multi-resistant organisms: larval therapy and debridement.
Read more01 Apr 2013
publication
Topically applied flightless I neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisita.
Read more01 Jan 2013
publication
The influence of Flightless I on Toll-like-receptor-mediated inflammation in a murine model of diabetic wound healing.
Read more01 Nov 2012
publication
Lysosomal secretion of Flightless I upon injury has the potential to alter inflammation.
Read more15 Sep 2012
publication
Flightless, secreted through a late endosome/lysosome pathway, binds LPS and dampens cytokine secretion.
Read more12 Sep 2012
publication
Cytoskeletal protein Flightless (Flii) is elevated in chronic and acute human wounds and wound fluid: neutralizing its activity in chronic but not acute wound fluid improves cellular proliferation.
Read more01 Aug 2009
publication